Found: 17
Select item for more details and to access through your institution.
Response to "Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?".
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 511, doi. 10.1002/psp4.13135
- By:
- Publication type:
- Article
Development of a cystic fibrosis population model for physiologically based pharmacokinetic models: Is it worth it?
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 509, doi. 10.1002/psp4.13134
- By:
- Publication type:
- Article
A systematic efficacy analysis of tuberculosis treatment with BPaL‐containing regimens using a multiscale modeling approach.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 673, doi. 10.1002/psp4.13117
- By:
- Publication type:
- Article
Understanding CYP3A4 and P‐gp mediated drug–drug interactions through PBPK modeling – Case example of pralsetinib.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 660, doi. 10.1002/psp4.13114
- By:
- Publication type:
- Article
Data‐driven disease progression model of Parkinson's disease and effect of sex and genetic variants.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 649, doi. 10.1002/psp4.13112
- By:
- Publication type:
- Article
Simulation‐based evaluation of personalized dosing approaches for anti‐FGFR/KLB bispecific antibody fazpilodemab.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 544, doi. 10.1002/psp4.13111
- By:
- Publication type:
- Article
In silico modeling and simulation of organ‐on‐a‐chip systems to support data analysis and a priori experimental design.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 524, doi. 10.1002/psp4.13110
- By:
- Publication type:
- Article
Application of multistate modeling to clinical data analysis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 513, doi. 10.1002/psp4.13109
- By:
- Publication type:
- Article
Pharmacokinetic/pharmacodynamic modeling of cortical dopamine concentrations after quetiapine lipid core nanocapsules administration to schizophrenia phenotyped rats.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 638, doi. 10.1002/psp4.13107
- By:
- Publication type:
- Article
Evaluation of the drug–drug interaction potential of brigatinib using a physiologically‐based pharmacokinetic modeling approach.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 624, doi. 10.1002/psp4.13106
- By:
- Publication type:
- Article
Quantitative modeling of tumor dynamics and development of drug resistance in non‐small cell lung cancer patients treated with erlotinib.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 612, doi. 10.1002/psp4.13105
- By:
- Publication type:
- Article
Tofacitinib pharmacokinetics in children and adolescents with juvenile idiopathic arthritis.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 599, doi. 10.1002/psp4.13104
- By:
- Publication type:
- Article
Physiologically‐based pharmacokinetic modeling of the drug–drug interaction between ivacaftor and lefamulin in cystic fibrosis patients.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 589, doi. 10.1002/psp4.13103
- By:
- Publication type:
- Article
Maximum likelihood estimation of renal transporter ontogeny profiles for pediatric PBPK modeling.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 576, doi. 10.1002/psp4.13102
- By:
- Publication type:
- Article
Physiologically‐based pharmacokinetic modeling of prominent oral contraceptive agents and applications in drug–drug interactions.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 563, doi. 10.1002/psp4.13101
- By:
- Publication type:
- Article
Population pharmacokinetic modeling of oral brepocitinib in healthy volunteers and patients with immuno‐inflammatory diseases.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 551, doi. 10.1002/psp4.13100
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 4, p. 505, doi. 10.1002/psp4.12987
- Publication type:
- Article